LISAvienna: October e-Newsletter with funding update und newsflash

Autumn means harvest time. The endeavors of the last months also pay off in the life sciences. An important highlight: Nabriva Therapeutics AG’s IPO

This edition of LISAvienna’s e-Newsletter presents ten relevant news from biotechnology, pharmaceutical Industry, medical device sector and the corresponding academic sectors in Vienna. As always, we also inform you on funding opportunities, deadlines and events.

>> read the current edition

The LISAvienna e-newsletter is free of charge and keeps you updated on hot news from the life sciences city of Vienna, ten times a year. >> e-newsletter archive and registration

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

LISAvienna: October e-Newsletter with funding update und newsflash

IMBA: ERC advanced grant for Julius Brennecke

Pharmig: EU-Pharma-Gesetzgebung: nach wie vor ein Kompromiss mit Schwächen

Schweizer Traditionsspital am Puls der Zeit - mit KI-basierter Bildanalyse von ImageBiopsy Lab